MQS Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,901
Closed -$471K 596
2025
Q2
$471K Buy
+5,901
New +$494K 0.26% 135
2024
Q4
Sell
-7,659
Closed -$552K 296
2024
Q3
$552K Buy
+7,659
New +$542K 0.31% 101
2024
Q1
Sell
-7,240
Closed -$443K 626
2023
Q4
$443K Buy
+7,240
New +$430K 0.25% 153
2022
Q4
Sell
-5,483
Closed -$273K 536
2022
Q3
$273K Buy
+5,483
New +$304K 0.18% 254
2022
Q2
Sell
-6,131
Closed -$325K 521
2022
Q1
$325K Buy
6,131
+2,725
+80% +$157K 0.26% 176
2021
Q4
$207K Buy
+3,406
New +$202K 0.33% 167

Other funds holding PBH

MQS Management's PBH Position: Q3 2025 in Review

MQS Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 5,901 shares — an estimated $471K sold.

MQS Management first reported a position in PBH in Q4 2021 and held it in 6 quarters. The position peaked at $552K in Q3 2024. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • MQS Management reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • MQS Management sold 5,901 Prestige Consumer Healthcare shares in Q3 2025, an estimated $471K.
  • MQS Management first reported a position in Prestige Consumer Healthcare in Q4 2021 and held it in 6 quarters.
  • MQS Management's Prestige Consumer Healthcare position peaked at $552K in Q3 2024.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on MQS Management's 13F filing for Q3 2025, filed 6 Nov 2025.